
Loading, please wait...

Loading, please wait...

Researchers have recently isolated several bioactive compounds from the fruits of Hypericum patulum, a plant commonly known as Goldencup St. John’s Wort. This discovery highlights the potential of Hypericum patulum anticancer activity in the ongoing search for natural therapeutic agents. The study identified twenty-eight prenylated acylphloroglucinols, including four novel compounds termed hypulatones C-F.
Among the newly discovered molecules, Compound 1 is particularly noteworthy as a rare meroterpenoid. It forms through the unique addition of a prenylated acylphloroglucinol unit to a sesquiterpenoid moiety. Furthermore, Compound 2, a spirocyclic polycyclic polyprenylated acylphloroglucinol, contains six chiral centers. Scientists established its relative configuration using advanced conformational analysis and NOE correlations. These structural complexities often correlate with specific biological interactions within human cells.
To assess the therapeutic potential of these isolates, the research team performed cytotoxic evaluations using the CCK-8 assay. They specifically tested the compounds against two human carcinoma cell lines: Huh-7 (hepatocellular carcinoma) and Panc-1 (pancreatic cancer). Consequently, the results revealed that compounds 6, 8, and 15 exhibited moderate antiproliferative activity. While these findings are preliminary, they provide a foundation for developing targeted natural therapies against challenging gastrointestinal malignancies.
Prenylated acylphloroglucinols (PPAPs) are a diverse class of plant secondary metabolites, primarily found in the Hypericum genus. They are known for their complex chemical structures and a wide range of biological activities, including antimicrobial and antitumor properties.
Huh-7 and Panc-1 are standard laboratory cell lines used to study liver and pancreatic cancers, respectively. Researchers use these models to screen for compounds that can effectively inhibit the growth of aggressive tumor cells.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Qiu YF et al. Prenylated acylphloroglucinols from the fruits of Hypericum patulum. Nat Prod Bioprospect. 2026 Apr 23. doi: undefined. PMID: 42020892.
Wu ZN et al. Hyperpatulones A–F, polycyclic polyprenylated acylphloroglucinols from Hypericum patulum and their cytotoxic activities. RSC Adv. 2019;9:8191-8199.
Qi CX et al. Hyparillums A and B: polycyclic polyprenylated acylphloroglucinols from Hypericum patulum. Chin J Nat Med. 2024;22(3):273-279.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New research isolates 28 compounds from Hypericum patulum, showing moderate antiproliferative activity against liver and pancreatic carcinoma cell lines....
6 months ago

Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today

A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday